Anna Kiyomi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Sensitive Detection

Rheumatoid Arthritis

Dendritic Cells

Transforming Growth Factor

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Drugs - real world outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Kiyomi, Fukiko Koizumi, Shinobu Imai, Hayato Yamana, Hiromasa Horiguchi, Kiyohide Fushimi, Munetoshi Sugiura
Bevacizumab-induced proteinuria and its association with antihypertensive drugs: A retrospective cohort study using a Japanese administrative database. PloS one 18 (8) (2023)
Hiroyuki Hashimoto, Shinobu Imai, Ryoka Yamashita, Anna Kiyomi, Munetoshi Sugiura
Association of Antipsychotic Drugs with the Risk of Recurrent Venous Thromboembolism: A Retrospective Study of Data from a Japanese Inpatient Database. Drugs - real world outcomes (2023)
Anna Kiyomi, Kensuke Yoshida, Chie Arai, Risa Usuki, Kyosuke Yamazaki, Naoto Hoshino, Akira Kurokawa, Shinobu Imai, Naoto Suzuki, Akira Toyama, Munetoshi Sugiura
Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study. PloS one 17 (4) (2022)
Kyosuke Yamazaki, Anna Kiyomi, Shinobu Imai, Munetoshi Sugiura
Saireito (114) Increases IC50 and Changes T-Cell Phenotype When Used in Combination with Prednisolone Therapy in Human Peripheral Blood Mononuclear Cells. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Anna Kiyomi, Ayaka Matsuda, Moeko Nara, Kyosuke Yamazaki, Shinobu Imai, Munetoshi Sugiura
Immunological Differences in Human Peripheral Blood Mononuclear Cells Treated with Traditional Japanese Herbal Medicines Hochuekkito, Juzentaihoto, and Ninjin'yoeito from Different Pharmaceutical Companies. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)